MENS Stock Summary and Trading Ideas (Jyong Biotech Ltd. - | NASDAQ:MENS)

Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.

Jyong Biotech Ltd. - trades on the NASDAQ stock market under the symbol MENS.

As of June 26, 2026, MENS stock price declined to $1.88 with 158,855 million shares trading.

MENS has a beta of 2.48, meaning it tends to be more sensitive to market movements. MENS has a correlation of 0.01 to the broad based SPY ETF.

MENS has a market cap of $142.93 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that MENS belongs to (by Net Assets): IBB, ONEQ, IBBQ, BIB.

MENS has underperformed the market in the last year with a return of -77.3%, while the SPY ETF gained +21.3%. In the last 3 month period, MENS fell short of the market, returning -10.0%, while SPY returned +11.3%. However, in the most recent 2 weeks MENS has outperformed the stock market by returning +10.3%, while SPY returned -0.9%.

MENS support price is $1.75 and resistance is $2.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MENS shares will trade within this expected range on the day.